Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI): characterizing disease severity and assessing responsiveness to clinical change

BACKGROUND: The Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) was developed for use in clinical trials and longitudinal patient assessment. OBJECTIVES: To characterize disease severity using the CDASI and assess responsiveness of this instrument to clinically meaningful changes i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Dermatol
Main Authors: Anyanwu, C.O., Fiorentino, D., Chung, L., Dzuong, C., Wang, Y., Okawa, J., Carr, K., Propert, K.J., Werth, V.P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878996/
https://ncbi.nlm.nih.gov/pubmed/25994337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.13915
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados